+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 1
Phase 2
Age: 18Years - 75Years
FEMALE
ID06596018

Evaluating Preoperative Stereotactic Body Radiation Therapy Added to Chemotherapy for Breast Cancer Patients Not Responding to Initial Neoadjuvant Treatment

Led by Second Affiliated Hospital, School of Medicine, Zhejiang University · Updated on 2025-12-30

96

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

This research aims to evaluate whether adding preoperative stereotactic body radiation therapy SBRT can improve pathological complete response pCR rates and safety for early or locally advanced breast cancer patients who do not respond to initial neoadjuvant chemotherapy. The study focuses on patients with breast adenocarcinoma who show stable or progressive disease after two cycles of standard chemotherapy. It investigates if combining SBRT with chemotherapy increases pCR and breast conservation rates, while also assessing safety and tolerability. Participants first receive standard neoadjuvant chemotherapy with tumor assessments after each cycle. Those identified as non-responders are randomly assigned to either continue chemotherapy alone or receive SBRT targeting the primary tumor with 8Gy daily for three days, followed by continued chemotherapy. After chemotherapy, all patients undergo standard surgery and whole-breast radiotherapy without an additional tumor boost. Throughout the study, participants undergo evaluations including physical exams, ultrasound, breast MRI, and laboratory tests. Researchers measure outcomes like pCR rates up to 21 weeks, breast conservation during surgery, 3-year local progression-free survival, overall survival, and treatment toxicities. Safety monitoring continues after chemotherapy, surgery, and radiotherapy, extending up to 30 weeks. The full study duration spans from treatment start through long-term follow-up.

CONDITIONS

Brief Title

Assessing Combined SBRT in Breast Cancer Non-Responders to Neoadjuvant Chemotherapy

Research Team

T

Ting Zhang

Y

Yucui Zhao

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here